Regentatlantic Capital LLC Vyne Therapeutics Inc. Transaction History

Regentatlantic Capital LLC

  • $3.34 Billion
  • Q3 2022

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.37 - $0.71 $9,277 - $17,803
25,075 New
25,075 $10,000

Others Institutions Holding VYNE

# of Institutions
2
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $184M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email